CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Elixens SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Elixens SA
83-85 blvd Vincent Auriol
Paris cedex 13
Phone: 33 156617280p:33 156617280 Paris, 75013  France Ticker: ELIXELIX
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Elixens SA, (formerly Orgasynth SA), is a France-based industrial company engaged in the provision of fragrances and flavorings. The Company's activities encompass growing and conversion of the aromatic plants to the design and production of flavorings or perfumed compounds. It offers essential oils, such as lavender, ylang ylang, orange, lemon, cypress, chamomile and peppermint; fragrances, including alcohol-based perfumes, beauty care products, air fresheners and cleaning products; flavors, such as fruits, flowers and plants, spices and condiments, vegetables and cheese, and other aromatic raw materials. The Company supplies a number of markets, comprising fine perfumery, cosmetics, food processing, pharmaceuticals and others. As of December 31, 2011, Elixens SA operated through subsidiaries like: Bambao, Elixens UK, Floressence, and Elixens France, among others. As of October 4, 2012, it acquired Eastaroma and Framaroma from its co-shareholder.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201212/31/2011Yes----

Industries
SIC Code Description
5169 Chemicals and allied products, not elsewhere classified
8731 Commercial physical and biological research
2899 Chemicals and chemical preparations, not elsewhere classified
2869 Industrial organic chemicals, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer EmmanuelAlves 77 6/13/2002
Deputy Chief Executive Officer, Director, Head of Financial Communication CaroleAbdelli 47 6/13/2002
Director of Finance, Director RichardMichalak 61 1/29/2008
Director BernardPommier 55 8/28/2008 8/28/2008

Business Names
Business Name
Agipal
Bio Inter
Eastaroma
6 additional Business Names available in full report.

General Information
Number of Employees: 201 (As of 12/31/2011)
Outstanding Shares: 2,021,807 (As of 6/30/2012)
Shareholders: 5,057
Stock Exchange: EPA
Fax Number: 33 156617299


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023